Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Total Voting Rights


Arix Bioscience PLC (ARIX)
Total Voting Rights

08-Feb-2022 / 07:20 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


Arix Bioscience plc

 

Total Voting Rights

LONDON, 8 February 2022: Arix Bioscience plc announces that its total issued share capital at the close of business on 7 Februry 2022 comprised 135,609,653 Ordinary Shares of 0.001 pence each fully paid. This figure includes 6,428,853 Ordinary Shares which are held in Treasury, leaving a balance of 129,180,800 Ordinary Shares with voting rights.             

The above figure of 129,180,800 may be used by shareholders for the calculations by which they will determine if they are required to notify their major interest in, or a change to their major interest in, Arix Bioscience plc under the Disclosure Guidance and Transparency Rules. 

 

[ENDS]

 

 

 

 

For more information on Arix, please contact:

 

Arix Bioscience plc

+44 (0)20 7290 1050

[email protected]

 

Powerscourt Group

Sarah MacLeod, Ibrahim Khalil

+44 (0)20 7250 1446

[email protected]

 

 

 

 



ISIN: GB00BD045071
Category Code: TVR
TIDM: ARIX
LEI Code: 213800OVT3AHQCXNIX43
OAM Categories: 2.5. Total number of voting rights and capital
Sequence No.: 141463
EQS News ID: 1277660

 
End of Announcement EQS News Service

fncls.ssp?fn=show_t_gif&application_id=1277660&application_name=news&site_id=sharewise
Like: 0
Share
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Legal notice

Comments